Total years of experience :275 years, 5 Months
As part of my duties, I was secretary of both the research committee and the Board of Directors. I also acted as
communications director of the research centre, both internal and external, including the organization of press
conferences, press releases, annual reports, publication of a monthly research bulletin, etc.
During the last three years, I was heavily involved in planning and enacting financing scenarios for the purpose of
financing research by means of initial public offerings. As a result of these financing packages, the CHUL research
centre was able to amass over $85 million in research contracts.
I coordinated the design and construction of the two new laboratory buildings of the Research Centre in 1987, at the
cost $6.8 million, plus scientific equipment amounting to $2.3 million and in 1998 for $31 million. These
responsibilities included the identification of different needs according to different sectors of activity—and their
integration into the project.
From 1993 to 1999, I have been closely involved in the implementation of Good Laboratory Practices (GLP) that
establish protocols for pre-clinical studies of new drugs and, since 1995, in the implementation of Good Clinical
Practices (GCP) used for Phase I and Phase II clinical studies as the manager of and responsible for the application
of the GLP and GCP standards at the CHUL Research Centre.
and conduct these interviews during filming.
• assimilate all this scientific information in such a way as to make it readily understandable to the public.
• present a final record of the research, containing all the information in an organized way, and giving the various
points of view.
• participate in production meetings, coordinate filming, and participate in filming and production of programs.
• write transitions and narrative links for the information gathered in the interviews, describe the events or
situations, or again establish links and transitions between two distinct parts of a program.
of all technologies related to life sciences to be sure to make good decisions in the investments I make and to identify
some external technologies that I can import in Quebec. One of my responsibilities is to maintain an equilibrium in
my portfolio (technologies, development stages, etc.).
Among my other responsibilities:
* Manage the Life Sciences investment team.
* Lead discussions and, with my team, establish the annual investment policies and objectives of my sectors.
* Approach the life sciences sector with a global, strategic, and proactive vision.
* Maintain and develop particularly good relations with analysts from all brokers in Canada and United States so
to be aware of good projects looking for financing and for co-investments in their financing deals.
Responsible for all operations of the Company (25 employees) specialized in digital health to develop an
early diagnosis of mental diseases: clinical trials, R&D for a new medical device and a «software-as-a-
medical-device», financials, human resources, security, IT, etc.
for conception and production of multiple scientific videos related to the last discoveries of a
major pharma company (Endoceutics)
* Conception, scenarios, and production of 5 scientific videos of 5 minutes to 30 minutes explaining the latest
discoveries of Endoceutics.
October 2015 - May 2016 and
February 2017- January 2018
ENDOCEUTICS
Project Director - Design and building of a cGMP pharmaceutical manufacturing facility
* Supervision of the construction of the facilities
* Negotiations with contractor
* Analysis and identification of specific requirements for cGMP manufacturing facilities, laboratories, and
head office
* Direct implication in the choice of architects and professionals
* Co-author the Functional and Technical Program for the manufacturing facility, laboratories, and head
office
* In direct relation with architects and engineers, elaborate the concept of the buildings and related budgets
* In direct relation with the high management of the City of Quebec, analyse the pros and cons of each ground
(terrain) susceptible to house the manufacturing facility - soil characteristics, topography, etc.
* Multidisciplinary team coordination between Endoceutics professionals, architects, and engineers to be sure
that the timeline and budget be respected
January 2011 - January 2019
UNIVERSANTÉ - IT DID NOT WORK
Co-founder
* Universanté was a project to create a new Canadian specialized television channel, associated with a
multimedia platform, exclusively dedicated to all aspects of health, medicine and diseases, mainly
informing the population about new biomedical at the national and international level, about new treatments
and diagnosis of diseases, about the factors that may influence our health as nutrition, management of health
systems, exercise, etc. discoveries
* Universanté would have discussed about health and business, biomedical careers, and will be the emergency
channel for the Ministry of Health in case of emergency or public health threat, like H1Ni;
* We had our Canadian broadcasting licence since February 2013 and were planning to launch the channel at
the beginning of 2015. It did not work.
Analysis of requirements for each sector: manufacturing facility for cGMP production of dopaminergic stem
cells and research laboratories
* In direct relation with the President and owner of the Company, Co-author the Functional and Technical
Program for the manufacturing facility and research laboratories
* Periodically, consultations with the President and owner of the Company on modifications on the
installations to be more efficient.
to the President & CEO, for Financing and Business Development
* Identify potential sources of financing and develop business partnership with national and/or international
companies in the biomedical domain mainly in the stem cell area and cell therapies
* Identification of potential companies for the development of new cellular therapies for degenerative diseases
* Negotiations (and closing) with one US and one Canadian company for the development, manufacturing
and clinical studies (phases II) of 5 new cell therapies for diseases without any effective treatment
* Strategic planning for the development of this promising field
1995 Advanced Training in Biomedical
in aeronauticals
* Turnaround, financing, operation, financial and human resources management (50 employees)
in life sciences (nutraceuticals)
* Turnaround, financing, operation, financial and human resources management (20 employees)
* Implementation of a professional accounting system
* Implementation of a sales management system
to the President & CEO of CHUM (
Restructuring and developing of the Research Center
* Turnaround plan including layoffs
* Find ways to give value to scientist’s discoveries & identification of technologies with commercialization
potential
* Intellectual property protection policy and its management: 5 patents obtained, 3 others deposited, 4 in
preparation and 2 trademarks obtained
* Increase the number of clinical research contracts with pharma industry
* Manage 56 professionals and a budget of 3 million $
* Strategic Planning
Curriculum vitae
Under the direction of Dr. Fernand Labrie, CHUL Research Centre was the largest French biomedical research
centre in Canada; with its 200 scientists and physicians who in 1998-1999 received more than $60 million in grants,
and research contracts. As executive director of the CHUL Research Centre, I was responsible for the:
• organization, both physical and administrative, of the research centre.
• communications of the research achievements of its scientists and relations with the organisms which invest
their money in research projects.
• management of the centre’s human resources (1, 100 people), material resources, and financial resources.
I was also responsible for analyzing the various projects of the centre, writing evaluative reports, and proposing
various alternatives to the science director of the research centre, to the research committee, and to the Board of
Directors.
Curriculum vitae
EndoCeutics is a biopharmaceutical company specialized in the final clinical development of treatments for breast
cancer and symptoms of the menopause.
My responsibilities were to manage the operations of this biotech company and to raise, through an IPO, an
investment for the final development of its products (75 million $).
Biogentis Biopharmaceuticals
Biogentis is a biopharmaceutical company based in Montreal specialized in the development and commercialization
of new technologies applied to advanced wound healing and tissue regeneration.
I am responsible for all the strategic development of the Company, including a financing round of about 15 million $
(mezzanine round plus a public financing concurrently with a merger with a public company), for regulatory
strategies for products development, for the identification of new technologies we can license-in to strengthen the
portfolio, for M&As, and for the internal and external communications of the company.
Investments, Life Sciences
Solidarity Fund QFL (
2 000 000 $
Labopharm 2002-2003 1 960 000 $
Total of money invested
(54 investments) 353 826 666 $
Curriculum vitae
23 000 000 $
Bioaxone Thérapeutique 2001-2002 3 000 000 $
Dermacor 2001-2002 2 600 000 $
Écopia Biosciences 2001-2002 4 500 000 $
GéminX 2001-2002 1 150 000 $
IPS Pharma 2001-2002 1 000 000 $
Labopharm 2001-2002 1 500 000 $
Laboratoires Aeterna 2001-2002 25 000 000 $
Néokimia 2001-2002 900 000 $
OTR Pharma 2001-2002 4 000 000 $
Phagetech 2001-2002 1 500 000 $
Theratechnologies 2001-2002 3 500 000 $
Topigen 2001-2002 2 400 000 $
MDS Life Sc. Technol. Fund II 2002-2003 50 000 000 $
Curriculum vitae
Same responsibilities than those in July 2005 to July 2007
* Design and construction of one new building for the Research Center (80, 000 square feet)
Curriculum vitae
Partial List of Investments under my responsibilities
Effective Collaboration between Research Institutions and Industry
I was responsible for its implementation and development.
The goal of this department was to introduce science and technology to students with no previous training in this
area. Seven professors made up the team. Some of this work was done simultaneously with my job as executive
director of research at CHUL.
and science researcher for the Radio-Québec program Nova
• gather information on scientific discoveries or novelties, linked to various events, situations, and people.
• study, analyze and interpret this information.
• write a preliminary text synthesizing the information thus gathered, presenting all aspects of science news so
that producers and animators were able to understand them.
and science researcher for the Radio-Canada television program Science-Réalité
My responsibilities were identical to those described above for Radio-Québec
Curriculum vitae
Coaching of employees
Certificate on Biotechnology and business
Biotechnology for Business
Certificate in Advanced Training in Biomedical Research Management
Séminaire St-Augustin, Quebec, Canada